Natural parasite exposure induces protective human anti-malarial antibodies

G Triller, SW Scally, G Costa, M Pissarev, C Kreschel… - Immunity, 2017 - cell.com
Antibodies against the NANP repeat of circumsporozoite protein (CSP), the major surface
antigen of Plasmodium falciparum (Pf) sporozoites, can protect from malaria in animal …

Evolution of protective human antibodies against Plasmodium falciparum circumsporozoite protein repeat motifs

R Murugan, SW Scally, G Costa, G Mustafa, E Thai… - Nature medicine, 2020 - nature.com
The circumsporozoite protein of the human malaria parasite Plasmodium falciparum
(PfCSP) is the main target of antibodies that prevent the infection and disease, as shown in …

Avid binding by B cells to the Plasmodium circumsporozoite protein repeat suppresses responses to protective subdominant epitopes

D Chatterjee, FJ Lewis, HJ Sutton, JA Kaczmarski… - Cell Reports, 2021 - cell.com
Antibodies targeting the NANP/NVDP repeat domain of the Plasmodium falciparum
circumsporozoite protein (CSP Repeat) can protect against malaria. However, it has also …

A potent anti-malarial human monoclonal antibody targets circumsporozoite protein minor repeats and neutralizes sporozoites in the liver

LT Wang, LS Pereira, Y Flores-Garcia, J O'Connor… - Immunity, 2020 - cell.com
Discovering potent human monoclonal antibodies (mAbs) targeting the Plasmodium
falciparum circumsporozoite protein (PfCSP) on sporozoites (SPZ) and elucidating their …

Vaccination in a humanized mouse model elicits highly protective PfCSP-targeting anti-malarial antibodies

S Kratochvil, CH Shen, YC Lin, K Xu, U Nair… - Immunity, 2021 - cell.com
Repeat antigens, such as the Plasmodium falciparum circumsporozoite protein (PfCSP), use
both sequence degeneracy and structural diversity to evade the immune response. A few …

Structural basis for antibody recognition of the NANP repeats in Plasmodium falciparum circumsporozoite protein

D Oyen, JL Torres, U Wille-Reece… - Proceedings of the …, 2017 - National Acad Sciences
Acquired resistance against antimalarial drugs has further increased the need for an
effective malaria vaccine. The current leading candidate, RTS, S, is a recombinant …

Affinity-matured homotypic interactions induce spectrum of PfCSP structures that influence protection from malaria infection

GM Martin, JL Torres, T Pholcharee, D Oyen… - Nature …, 2023 - nature.com
The generation of high-quality antibody responses to Plasmodium falciparum (Pf)
circumsporozoite protein (PfCSP), the primary surface antigen of Pf sporozoites, is …

A novel CSP C-terminal epitope targeted by an antibody with protective activity against Plasmodium falciparum

N Beutler, T Pholcharee, D Oyen… - PLoS …, 2022 - journals.plos.org
Potent and durable vaccine responses will be required for control of malaria caused by
Plasmodium falciparum (Pf). RTS, S/AS01 is the first, and to date, the only vaccine that has …

Rare PfCSP C-terminal antibodies induced by live sporozoite vaccination are ineffective against malaria infection

SW Scally, R Murugan, A Bosch, G Triller… - Journal of Experimental …, 2018 - rupress.org
Antibodies against the central repeat of the Plasmodium falciparum (Pf) circumsporozoite
protein (CSP) inhibit parasite activity and correlate with protection from malaria. However …

T-dependent B cell responses to Plasmodium induce antibodies that form a high-avidity multivalent complex with the circumsporozoite protein

CR Fisher, HJ Sutton, JA Kaczmarski… - PLoS …, 2017 - journals.plos.org
The repeat region of the Plasmodium falciparum circumsporozoite protein (CSP) is a major
vaccine antigen because it can be targeted by parasite neutralizing antibodies; however …